Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal bleeding (HP:0001892)help
Grandparent Node:
expand
Vascular skin abnormality (HP:0011276)help
Parent Node:
expand
Subcutaneous hemorrhage (HP:0001933)help
..Starting node
..expand
Bruising susceptibility (HP:0000978)help
Term ID: 978
Name: Bruising susceptibility
Synonym: Bruisability; Bruise easily; Bruising susceptibility; Easy bruisability; Easy bruising
Definition: An ecchymosis (bruise) refers to the skin discoloration caused by the escape of blood into the tissues from ruptured blood vessels. This term refers to an abnormally increased susceptibility to bruising. The corresponding phenotypic abnormality is generally elicited on medical history as a report of frequent ecchymoses or bruising without adequate trauma.
Comments:
Reference: HP:0000978
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandPurpura (HP:0000979) help
..expandSpontaneous hematomas (HP:0007420) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0000978HP:0000978Bruising susceptibility0ABCC6 CL E G H36857ORPHA:758Pseudoxanthoma elasticumHP:0040282 - Frequent415
HP:0000978HP:0000978Bruising susceptibility0ACTA2 CL E G H59130ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional94
HP:0000978HP:0000978Bruising susceptibility0ADAMTS2 CL E G H9509218OMIM:225410Ehlers-Danlos syndrome, type VII, autosomal recessive.165
HP:0000978HP:0000978Bruising susceptibility0AEBP1 CL E G H165303ORPHA:536532Classical-like Ehlers-Danlos syndrome type 2HP:0040281 - Very frequent
HP:0000978HP:0000978Bruising susceptibility0AEBP1 CL E G H165303OMIM:618000Ehlers-Danlos syndrome, classic-like, 2.
HP:0000978HP:0000978Bruising susceptibility0AIP CL E G H9049358OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.95
HP:0000978HP:0000978Bruising susceptibility0ANKRD26 CL E G H2285229186OMIM:188000THROMBOCYTOPENIA 2; THC2106
HP:0000978HP:0000978Bruising susceptibility0ARMC5 CL E G H7979825781ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasiaHP:0040282 - Frequent7
HP:0000978HP:0000978Bruising susceptibility0ATP7A CL E G H538869OMIM:304150Occipital horn syndrome.192
HP:0000978HP:0000978Bruising susceptibility0ATP7A CL E G H538869ORPHA:198Occipital horn syndromeHP:0040282 - Frequent192
HP:0000978HP:0000978Bruising susceptibility0ATP7B CL E G H540870ORPHA:905Wilson diseaseHP:0040281 - Very frequent315
HP:0000978HP:0000978Bruising susceptibility0ATRX CL E G H546886ORPHA:231401Alpha-thalassemia-myelodysplastic syndromeHP:0040282 - Frequent169
HP:0000978HP:0000978Bruising susceptibility0ATRX CL E G H546886ORPHA:96253Cushing diseaseHP:0040282 - Frequent169
HP:0000978HP:0000978Bruising susceptibility0B3GALT6 CL E G H12679217978ORPHA:536467B3GALT6-related spondylodysplastic Ehlers-Danlos syndromeHP:0040282 - Frequent38
HP:0000978HP:0000978Bruising susceptibility0BCOR CL E G H5488020893ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent101
HP:0000978HP:0000978Bruising susceptibility0BLOC1S3 CL E G H38855220914OMIM:614077Hermansky-Pudlak syndrome 8.42
HP:0000978HP:0000978Bruising susceptibility0BLOC1S5 CL E G H6391518561OMIM:619172HERMANSKY-PUDLAK SYNDROME 11; HPS11
HP:0000978HP:0000978Bruising susceptibility0BRAF CL E G H6731097ORPHA:96253Cushing diseaseHP:0040282 - Frequent276
HP:0000978HP:0000978Bruising susceptibility0BRAF CL E G H6731097OMIM:163950Noonan syndrome 1276
HP:0000978HP:0000978Bruising susceptibility0C1R CL E G H7151246OMIM:130080Ehlers-Danlos syndrome, periodontal type, 1.15
HP:0000978HP:0000978Bruising susceptibility0C1S CL E G H7161247OMIM:617174Ehlers-Danlos syndrome, periodontal type, 2.7
HP:0000978HP:0000978Bruising susceptibility0CASP10 CL E G H8431500ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040282 - Frequent87
HP:0000978HP:0000978Bruising susceptibility0CDH23 CL E G H6407213733ORPHA:96253Cushing diseaseHP:0040282 - Frequent636
HP:0000978HP:0000978Bruising susceptibility0CHST14 CL E G H11318924464OMIM:601776Ehlers-Danlos syndrome, musculocontractural type 1.27
HP:0000978HP:0000978Bruising susceptibility0CHST14 CL E G H11318924464ORPHA:2953Musculocontractural Ehlers-Danlos syndromeHP:0040281 - Very frequent27
HP:0000978HP:0000978Bruising susceptibility0CLCN7 CL E G H11862025ORPHA:667Autosomal recessive malignant osteopetrosisHP:0040283 - Occasional102
HP:0000978HP:0000978Bruising susceptibility0COL1A1 CL E G H12772197ORPHA:287Classical Ehlers-Danlos syndromeHP:0040283 - Occasional373
HP:0000978HP:0000978Bruising susceptibility0COL1A1 CL E G H12772197OMIM:619115COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 1; OIEDS1373
HP:0000978HP:0000978Bruising susceptibility0COL1A1 CL E G H12772197OMIM:130060Ehlers-Danlos syndrome, arthrochalasia type, 1.373
HP:0000978HP:0000978Bruising susceptibility0COL1A1 CL E G H12772197OMIM:166200Osteogenesis imperfecta, type I.373
HP:0000978HP:0000978Bruising susceptibility0COL1A2 CL E G H12782198ORPHA:230851Cardiac-valvular Ehlers-Danlos syndromeHP:0040282 - Frequent243
HP:0000978HP:0000978Bruising susceptibility0COL1A2 CL E G H12782198OMIM:619120COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 2; OIEDS2243
HP:0000978HP:0000978Bruising susceptibility0COL1A2 CL E G H12782198OMIM:617821Ehlers-Danlos syndrome, arthrochalasia type, 2.243
HP:0000978HP:0000978Bruising susceptibility0COL1A2 CL E G H12782198OMIM:225320Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form.243
HP:0000978HP:0000978Bruising susceptibility0COL3A1 CL E G H12812201OMIM:130050Ehlers-Danlos syndrome, Vascular type749
HP:0000978HP:0000978Bruising susceptibility0COL3A1 CL E G H12812201OMIM:618343Polymicrogyria with or without vascular-type ehlers-danlos syndrome.749
HP:0000978HP:0000978Bruising susceptibility0COL3A1 CL E G H12812201ORPHA:286Vascular Ehlers-Danlos syndromeHP:0040281 - Very frequent749
HP:0000978HP:0000978Bruising susceptibility0COL5A1 CL E G H12892209ORPHA:287Classical Ehlers-Danlos syndromeHP:0040283 - Occasional660
HP:0000978HP:0000978Bruising susceptibility0COL5A1 CL E G H12892209OMIM:130000Ehlers-danlos syndrome, type I660
HP:0000978HP:0000978Bruising susceptibility0COL5A2 CL E G H12902210ORPHA:287Classical Ehlers-Danlos syndromeHP:0040283 - Occasional325
HP:0000978HP:0000978Bruising susceptibility0COL5A2 CL E G H12902210OMIM:130010Ehlers-Danlos syndrome, classic type, 2325
HP:0000978HP:0000978Bruising susceptibility0CREB3L1 CL E G H9099318856OMIM:616229Osteogenesis imperfecta, type XVI4
HP:0000978HP:0000978Bruising susceptibility0DSE CL E G H2994021144ORPHA:2953Musculocontractural Ehlers-Danlos syndromeHP:0040281 - Very frequent13
HP:0000978HP:0000978Bruising susceptibility0DTNBP1 CL E G H8406217328OMIM:614076Hermansky-Pudlak syndrome 7.46
HP:0000978HP:0000978Bruising susceptibility0ELN CL E G H20063327ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional172
HP:0000978HP:0000978Bruising susceptibility0EMILIN1 CL E G H1111719880OMIM:6200802
HP:0000978HP:0000978Bruising susceptibility0ENPP1 CL E G H51673356ORPHA:758Pseudoxanthoma elasticumHP:0040282 - Frequent151
HP:0000978HP:0000978Bruising susceptibility0ETV6 CL E G H21203495OMIM:616216Thrombocytopenia 5.13
HP:0000978HP:0000978Bruising susceptibility0F10 CL E G H21593528ORPHA:328Congenital factor X deficiencyHP:0040283 - Occasional33
HP:0000978HP:0000978Bruising susceptibility0F13A1 CL E G H21623531ORPHA:331Congenital factor XIII deficiencyHP:0040282 - Frequent60
HP:0000978HP:0000978Bruising susceptibility0F13A1 CL E G H21623531OMIM:613225Factor XIII, A subunit, deficiency of.60
HP:0000978HP:0000978Bruising susceptibility0F13B CL E G H21653534ORPHA:331Congenital factor XIII deficiencyHP:0040282 - Frequent32
HP:0000978HP:0000978Bruising susceptibility0F13B CL E G H21653534OMIM:613235Factor XIIIB deficiency.32
HP:0000978HP:0000978Bruising susceptibility0F2 CL E G H21473535OMIM:613679Congenital prothrombin deficiency.44
HP:0000978HP:0000978Bruising susceptibility0F5 CL E G H21533542ORPHA:326Congenital factor V deficiencyHP:0040283 - Occasional159
HP:0000978HP:0000978Bruising susceptibility0F5 CL E G H21533542OMIM:227400Factor V deficiency.159
HP:0000978HP:0000978Bruising susceptibility0F7 CL E G H21553544ORPHA:327Congenital factor VII deficiencyHP:0040282 - Frequent70
HP:0000978HP:0000978Bruising susceptibility0F8 CL E G H21573546ORPHA:177926Bleeding disorder in hemophilia A carriers without FVIII deficiencyHP:0040281 - Very frequent303
HP:0000978HP:0000978Bruising susceptibility0F8 CL E G H21573546OMIM:306700Hemophilia A.303
HP:0000978HP:0000978Bruising susceptibility0F8 CL E G H21573546ORPHA:169802Severe hemophilia AHP:0040282 - Frequent303
HP:0000978HP:0000978Bruising susceptibility0FANCA CL E G H21753582OMIM:227650Fanconi anemia.340
HP:0000978HP:0000978Bruising susceptibility0FANCC CL E G H21763584OMIM:227645Fanconi anemia, complementation group C.410
HP:0000978HP:0000978Bruising susceptibility0FANCD2 CL E G H21773585OMIM:227646Fanconi anemia, complementation group D2.147
HP:0000978HP:0000978Bruising susceptibility0FANCE CL E G H21783586OMIM:600901Fanconi anemia, complementation group E.73
HP:0000978HP:0000978Bruising susceptibility0FAS CL E G H35511920ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040282 - Frequent59
HP:0000978HP:0000978Bruising susceptibility0FASLG CL E G H35611936ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040282 - Frequent37
HP:0000978HP:0000978Bruising susceptibility0FBN1 CL E G H22003603ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional1361
HP:0000978HP:0000978Bruising susceptibility0FBN1 CL E G H22003603OMIM:616914Marfan lipodystrophy syndrome1361
HP:0000978HP:0000978Bruising susceptibility0FCGR2C CL E G H910315626ORPHA:3002Immune thrombocytopeniaHP:0040283 - Occasional
HP:0000978HP:0000978Bruising susceptibility0FGA CL E G H22433661OMIM:202400Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included47
HP:0000978HP:0000978Bruising susceptibility0FGB CL E G H22443662OMIM:202400Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included62
HP:0000978HP:0000978Bruising susceptibility0FGG CL E G H22663694OMIM:202400Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included34
HP:0000978HP:0000978Bruising susceptibility0FIP1L1 CL E G H8160819124ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent4
HP:0000978HP:0000978Bruising susceptibility0FKBP14 CL E G H5503318625OMIM:614557Ehlers-Danlos syndrome, kyphoscoliotic type, 2HP:0040283 - Occasional13
HP:0000978HP:0000978Bruising susceptibility0FKBP14 CL E G H5503318625ORPHA:300179Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiencyHP:0040282 - Frequent13
HP:0000978HP:0000978Bruising susceptibility0FLNA CL E G H23163754ORPHA:75497X-linked Ehlers-Danlos syndromeHP:0040281 - Very frequent493
HP:0000978HP:0000978Bruising susceptibility0FOXE3 CL E G H23013808ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional23
HP:0000978HP:0000978Bruising susceptibility0GATA1 CL E G H26234170OMIM:314050Thrombocytopenia with beta-thalassemia, X-linked.29
HP:0000978HP:0000978Bruising susceptibility0GATA1 CL E G H26234170OMIM:300367Thrombocytopenia, X-linked, with or without dyserythropoietic anemia.29
HP:0000978HP:0000978Bruising susceptibility0GATA2 CL E G H26244171ORPHA:3226Deafness-lymphedema-leukemia syndromeHP:0040282 - Frequent137
HP:0000978HP:0000978Bruising susceptibility0GBA1 CL E G H26294177ORPHA:77259Gaucher disease type 1HP:0040282 - Frequent
HP:0000978HP:0000978Bruising susceptibility0GFI1B CL E G H83284238OMIM:187900Bleeding disorder, platelet-type, 17.3
HP:0000978HP:0000978Bruising susceptibility0GGCX CL E G H26774247OMIM:277450VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1.129
HP:0000978HP:0000978Bruising susceptibility0GNAS CL E G H27784392OMIM:219080ACTH-independent macronodular adrenal hyperplasia.101
HP:0000978HP:0000978Bruising susceptibility0GNAS CL E G H27784392ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasiaHP:0040282 - Frequent101
HP:0000978HP:0000978Bruising susceptibility0GP1BA CL E G H28114439ORPHA:274Bernard-Soulier syndromeHP:0040283 - Occasional23
HP:0000978HP:0000978Bruising susceptibility0GP1BA CL E G H28114439OMIM:153670Bernard-Soulier syndrome, type A2, autosomal dominant.23
HP:0000978HP:0000978Bruising susceptibility0GP1BB CL E G H28124440ORPHA:274Bernard-Soulier syndromeHP:0040283 - Occasional8
HP:0000978HP:0000978Bruising susceptibility0GP6 CL E G H5120614388OMIM:614201Bleeding disorder, platelet-type, 11.24
HP:0000978HP:0000978Bruising susceptibility0GP9 CL E G H28154444ORPHA:274Bernard-Soulier syndromeHP:0040283 - Occasional21
HP:0000978HP:0000978Bruising susceptibility0GSN CL E G H29344620ORPHA:85448AGel amyloidosisHP:0040282 - Frequent53
HP:0000978HP:0000978Bruising susceptibility0HBA1 CL E G H30394823ORPHA:98791Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16HP:0040282 - Frequent200
HP:0000978HP:0000978Bruising susceptibility0HBA2 CL E G H30404824ORPHA:98791Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16HP:0040282 - Frequent88
HP:0000978HP:0000978Bruising susceptibility0HEY2 CL E G H234934881ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional
HP:0000978HP:0000978Bruising susceptibility0HPS1 CL E G H32575163OMIM:203300Hermansky-Pudlak syndrome 1.121
HP:0000978HP:0000978Bruising susceptibility0HPS3 CL E G H8434315597OMIM:614072Hermansky-Pudlak syndrome 3.67
HP:0000978HP:0000978Bruising susceptibility0HPS4 CL E G H8978115844OMIM:614073Hermansky-Pudlak syndrome 4.123
HP:0000978HP:0000978Bruising susceptibility0HPS5 CL E G H1123417022OMIM:614074Hermansky-Pudlak syndrome 5.105
HP:0000978HP:0000978Bruising susceptibility0HPS6 CL E G H7980318817OMIM:614075Hermansky-Pudlak syndrome 6.45
HP:0000978HP:0000978Bruising susceptibility0IPO8 CL E G H105269853ORPHA:60030Loeys-Dietz syndromeHP:0040283 - Occasional
HP:0000978HP:0000978Bruising susceptibility0IPO8 CL E G H105269853OMIM:619472VISS syndrome
HP:0000978HP:0000978Bruising susceptibility0IRF2BP2 CL E G H35994821729ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent4
HP:0000978HP:0000978Bruising susceptibility0ITGA2B CL E G H36746138ORPHA:849Glanzmann thrombastheniaHP:0040282 - Frequent69
HP:0000978HP:0000978Bruising susceptibility0ITGA2B CL E G H36746138OMIM:273800Glanzmann thrombasthenia.69
HP:0000978HP:0000978Bruising susceptibility0ITGB3 CL E G H36906156ORPHA:849Glanzmann thrombastheniaHP:0040282 - Frequent80
HP:0000978HP:0000978Bruising susceptibility0ITGB3 CL E G H36906156OMIM:619267GLANZMANN THROMBASTHENIA 2; GT280
HP:0000978HP:0000978Bruising susceptibility0JAK2 CL E G H37176192ORPHA:729Polycythemia veraHP:0040281 - Very frequent57
HP:0000978HP:0000978Bruising susceptibility0KRAS CL E G H38456407OMIM:609942Noonan syndrome 3196
HP:0000978HP:0000978Bruising susceptibility0LMAN1 CL E G H39986631ORPHA:35909Combined deficiency of factor V and factor VIIIHP:0040282 - Frequent56
HP:0000978HP:0000978Bruising susceptibility0LOX CL E G H40156664ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional6
HP:0000978HP:0000978Bruising susceptibility0LYST CL E G H11301968ORPHA:352723Attenuated Chédiak-Higashi syndromeHP:0040281 - Very frequent239
HP:0000978HP:0000978Bruising susceptibility0LYST CL E G H11301968ORPHA:167Chédiak-Higashi syndromeHP:0040282 - Frequent239
HP:0000978HP:0000978Bruising susceptibility0LYST CL E G H11301968OMIM:214500Chediak-Higashi syndrome239
HP:0000978HP:0000978Bruising susceptibility0MAP2K1 CL E G H56046840OMIM:163950Noonan syndrome 1134
HP:0000978HP:0000978Bruising susceptibility0MAPK1 CL E G H55946871OMIM:619087NOONAN SYNDROME 13; NS132
HP:0000978HP:0000978Bruising susceptibility0MAT2A CL E G H41446904ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional13
HP:0000978HP:0000978Bruising susceptibility0MCFD2 CL E G H9041118451ORPHA:35909Combined deficiency of factor V and factor VIIIHP:0040282 - Frequent77
HP:0000978HP:0000978Bruising susceptibility0MFAP5 CL E G H807629673ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional11
HP:0000978HP:0000978Bruising susceptibility0MPL CL E G H43527217ORPHA:729Polycythemia veraHP:0040281 - Very frequent97
HP:0000978HP:0000978Bruising susceptibility0MTAP CL E G H45077413OMIM:112250Diaphyseal medullary stenosis with malignant fibrous histiocytomaHP:0040283 - Occasional85
HP:0000978HP:0000978Bruising susceptibility0MYH11 CL E G H46297569ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional418
HP:0000978HP:0000978Bruising susceptibility0MYH9 CL E G H46277579OMIM:155100Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss.297
HP:0000978HP:0000978Bruising susceptibility0MYH9 CL E G H46277579ORPHA:182050MYH9-related diseaseHP:0040282 - Frequent297
HP:0000978HP:0000978Bruising susceptibility0MYLK CL E G H46387590ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional326
HP:0000978HP:0000978Bruising susceptibility0NABP1 CL E G H6485926232ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent
HP:0000978HP:0000978Bruising susceptibility0NBEAL2 CL E G H2321831928OMIM:139090Gray platelet syndrome.127
HP:0000978HP:0000978Bruising susceptibility0NBEAL2 CL E G H2321831928ORPHA:721Gray platelet syndromeHP:0040281 - Very frequent127
HP:0000978HP:0000978Bruising susceptibility0NFIX CL E G H47847788ORPHA:561Marshall-Smith syndromeHP:0040282 - Frequent40
HP:0000978HP:0000978Bruising susceptibility0NPM1 CL E G H48697910ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent12
HP:0000978HP:0000978Bruising susceptibility0NR3C1 CL E G H29087978ORPHA:96253Cushing diseaseHP:0040282 - Frequent79
HP:0000978HP:0000978Bruising susceptibility0NTRK1 CL E G H49148031ORPHA:642Hereditary sensory and autonomic neuropathy type 4HP:0040283 - Occasional97
HP:0000978HP:0000978Bruising susceptibility0NUMA1 CL E G H49268059ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent
HP:0000978HP:0000978Bruising susceptibility0P2RY12 CL E G H6480518124OMIM:609821Bleeding disorder, platelet-type, 85
HP:0000978HP:0000978Bruising susceptibility0PDE11A CL E G H509408773ORPHA:1359Carney complex13
HP:0000978HP:0000978Bruising susceptibility0PDE11A CL E G H509408773OMIM:610475Pigmented nodular adrenocortical disease, primary, 2.13
HP:0000978HP:0000978Bruising susceptibility0PDE11A CL E G H509408773ORPHA:189439Primary pigmented nodular adrenocortical disease13
HP:0000978HP:0000978Bruising susceptibility0PDE8B CL E G H86228794ORPHA:189439Primary pigmented nodular adrenocortical disease75
HP:0000978HP:0000978Bruising susceptibility0PLAU CL E G H53289052OMIM:601709Quebec platelet disorder.50
HP:0000978HP:0000978Bruising susceptibility0PLEC CL E G H53399069OMIM:131950Epidermolysis bullosa simplex, Ogna type.759
HP:0000978HP:0000978Bruising susceptibility0PLOD1 CL E G H53519081OMIM:225400Ehlers-Danlos syndrome, kyphoscoliotic type, 1105
HP:0000978HP:0000978Bruising susceptibility0PLOD1 CL E G H53519081ORPHA:1900Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiencyHP:0040281 - Very frequent105
HP:0000978HP:0000978Bruising susceptibility0PLOD3 CL E G H89859083OMIM:612394Bone fragility with contractures, arterial rupture, and deafness.5
HP:0000978HP:0000978Bruising susceptibility0PML CL E G H53719113ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent3
HP:0000978HP:0000978Bruising susceptibility0PRDM5 CL E G H111079349ORPHA:90354Brittle cornea syndromeHP:0040282 - Frequent58
HP:0000978HP:0000978Bruising susceptibility0PRF1 CL E G H55519360ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040283 - Occasional58
HP:0000978HP:0000978Bruising susceptibility0PRKACA CL E G H55669380OMIM:615830Pigmented nodular adrenocortical disease, primary, 4.2
HP:0000978HP:0000978Bruising susceptibility0PRKACA CL E G H55669380ORPHA:189439Primary pigmented nodular adrenocortical disease2
HP:0000978HP:0000978Bruising susceptibility0PRKAR1A CL E G H55739388ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent134
HP:0000978HP:0000978Bruising susceptibility0PRKAR1A CL E G H55739388ORPHA:1359Carney complex134
HP:0000978HP:0000978Bruising susceptibility0PRKAR1A CL E G H55739388OMIM:610489Pigmented nodular adrenocortical disease, primary, 1.134
HP:0000978HP:0000978Bruising susceptibility0PRKAR1A CL E G H55739388ORPHA:189439Primary pigmented nodular adrenocortical disease134
HP:0000978HP:0000978Bruising susceptibility0PRKCD CL E G H55809399ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040282 - Frequent10
HP:0000978HP:0000978Bruising susceptibility0PRKG1 CL E G H55929414ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional41
HP:0000978HP:0000978Bruising susceptibility0PTPN11 CL E G H57819644OMIM:163950Noonan syndrome 1291
HP:0000978HP:0000978Bruising susceptibility0PYCR1 CL E G H58319721OMIM:612940Cutis laxa, autosomal recessive, type IIB53
HP:0000978HP:0000978Bruising susceptibility0RARA CL E G H59149864ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent2
HP:0000978HP:0000978Bruising susceptibility0RASGRP1 CL E G H101259878ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040282 - Frequent
HP:0000978HP:0000978Bruising susceptibility0RIN2 CL E G H5445318750OMIM:613075Macs syndrome.43
HP:0000978HP:0000978Bruising susceptibility0RIN2 CL E G H5445318750ORPHA:217335RIN2 syndromeHP:0040282 - Frequent43
HP:0000978HP:0000978Bruising susceptibility0RUNX1 CL E G H86110471OMIM:601399Platelet disorder, familial, with associated myeloid malignancy.181
HP:0000978HP:0000978Bruising susceptibility0SCARB2 CL E G H9501665ORPHA:77259Gaucher disease type 1HP:0040282 - Frequent77
HP:0000978HP:0000978Bruising susceptibility0SERPINF2 CL E G H53459075ORPHA:79Congenital alpha2-antiplasmin deficiencyHP:0040283 - Occasional8
HP:0000978HP:0000978Bruising susceptibility0SERPINF2 CL E G H53459075OMIM:262850Plasmin inhibitor deficiency.8
HP:0000978HP:0000978Bruising susceptibility0SIK3 CL E G H2338729165OMIM:618162Spondyloepimetaphyseal dysplasia, Krakow type.
HP:0000978HP:0000978Bruising susceptibility0SLC2A10 CL E G H8103113444OMIM:208050Arterial tortuosity syndrome.178
HP:0000978HP:0000978Bruising susceptibility0SLC37A4 CL E G H25424061ORPHA:79259Glycogen storage disease due to glucose-6-phosphatase deficiency type IbHP:0040283 - Occasional110
HP:0000978HP:0000978Bruising susceptibility0SLC39A13 CL E G H9125220859OMIM:612350Ehlers-Danlos syndrome, spondylodysplastic type, 3.24
HP:0000978HP:0000978Bruising susceptibility0SLC39A13 CL E G H9125220859ORPHA:157965SLC39A13-related spondylodysplastic Ehlers-Danlos syndromeHP:0040281 - Very frequent24
HP:0000978HP:0000978Bruising susceptibility0SLC51A CL E G H20093129955OMIM:619484CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 6; PFIC6
HP:0000978HP:0000978Bruising susceptibility0SLFN14 CL E G H34261832689OMIM:616913Bleeding disorder, platelet-type, 20.6
HP:0000978HP:0000978Bruising susceptibility0SMAD2 CL E G H40876768ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional7
HP:0000978HP:0000978Bruising susceptibility0SMAD3 CL E G H40886769ORPHA:284984Aneurysm-osteoarthritis syndromeHP:0040282 - Frequent260
HP:0000978HP:0000978Bruising susceptibility0SMAD3 CL E G H40886769ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional260
HP:0000978HP:0000978Bruising susceptibility0SMAD3 CL E G H40886769OMIM:613795LOEYS-DIETZ SYNDROME 3; LDS3260
HP:0000978HP:0000978Bruising susceptibility0SMAD4 CL E G H40896770ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional504
HP:0000978HP:0000978Bruising susceptibility0SNX10 CL E G H2988714974ORPHA:667Autosomal recessive malignant osteopetrosisHP:0040283 - Occasional2
HP:0000978HP:0000978Bruising susceptibility0SOS1 CL E G H665411187OMIM:610733Noonan syndrome 4315
HP:0000978HP:0000978Bruising susceptibility0SPRED2 CL E G H20073417722OMIM:619745NOONAN SYNDROME 14; NS14
HP:0000978HP:0000978Bruising susceptibility0STAT3 CL E G H677411364ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent110
HP:0000978HP:0000978Bruising susceptibility0STAT5B CL E G H677711367ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent12
HP:0000978HP:0000978Bruising susceptibility0STX11 CL E G H867611429ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040283 - Occasional85
HP:0000978HP:0000978Bruising susceptibility0STXBP2 CL E G H681311445ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040283 - Occasional70
HP:0000978HP:0000978Bruising susceptibility0TBL1XR1 CL E G H7971829529ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent22
HP:0000978HP:0000978Bruising susceptibility0TBXA2R CL E G H691511608OMIM:614009BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT1310
HP:0000978HP:0000978Bruising susceptibility0TCIRG1 CL E G H1031211647ORPHA:667Autosomal recessive malignant osteopetrosisHP:0040283 - Occasional82
HP:0000978HP:0000978Bruising susceptibility0TET2 CL E G H5479025941ORPHA:729Polycythemia veraHP:0040281 - Very frequent3
HP:0000978HP:0000978Bruising susceptibility0TGFB2 CL E G H704211768ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional162
HP:0000978HP:0000978Bruising susceptibility0TGFB2 CL E G H704211768OMIM:614816LOEYS-DIETZ SYNDROME 4; LDS4162
HP:0000978HP:0000978Bruising susceptibility0TGFB3 CL E G H704311769ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional85
HP:0000978HP:0000978Bruising susceptibility0TGFB3 CL E G H704311769OMIM:615582LOEYS-DIETZ SYNDROME 5; LDS585
HP:0000978HP:0000978Bruising susceptibility0TGFBR1 CL E G H704611772ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional239
HP:0000978HP:0000978Bruising susceptibility0TGFBR1 CL E G H704611772ORPHA:60030Loeys-Dietz syndromeHP:0040283 - Occasional239
HP:0000978HP:0000978Bruising susceptibility0TGFBR2 CL E G H704811773ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional253
HP:0000978HP:0000978Bruising susceptibility0TGFBR2 CL E G H704811773ORPHA:60030Loeys-Dietz syndromeHP:0040283 - Occasional253
HP:0000978HP:0000978Bruising susceptibility0TNFRSF1A CL E G H713211916ORPHA:32960Tumor necrosis factor receptor 1 associated periodic syndromeHP:0040283 - Occasional131
HP:0000978HP:0000978Bruising susceptibility0TNFSF11 CL E G H860011926ORPHA:667Autosomal recessive malignant osteopetrosisHP:0040283 - Occasional44
HP:0000978HP:0000978Bruising susceptibility0TNXB CL E G H714811976ORPHA:230839Classical-like Ehlers-Danlos syndrome type 1HP:0040282 - Frequent134
HP:0000978HP:0000978Bruising susceptibility0TNXB CL E G H714811976OMIM:606408Ehlers-Danlos syndrome, classic-like.134
HP:0000978HP:0000978Bruising susceptibility0TP53 CL E G H715711998ORPHA:96253Cushing diseaseHP:0040282 - Frequent911
HP:0000978HP:0000978Bruising susceptibility0UNC13D CL E G H20129423147ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040283 - Occasional116
HP:0000978HP:0000978Bruising susceptibility0USP48 CL E G H8419618533ORPHA:96253Cushing diseaseHP:0040282 - Frequent1
HP:0000978HP:0000978Bruising susceptibility0USP8 CL E G H910112631ORPHA:96253Cushing diseaseHP:0040282 - Frequent7
HP:0000978HP:0000978Bruising susceptibility0USP8 CL E G H910112631OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.7
HP:0000978HP:0000978Bruising susceptibility0VWF CL E G H745012726OMIM:193400Von willebrand disease, type 1533
HP:0000978HP:0000978Bruising susceptibility0VWF CL E G H745012726OMIM:613554Von willebrand disease, type 2.533
HP:0000978HP:0000978Bruising susceptibility0VWF CL E G H745012726OMIM:277480Von willebrand disease, type 3.533
HP:0000978HP:0000978Bruising susceptibility0WAS CL E G H745412731OMIM:313900Thrombocytopenia 1.65
HP:0000978HP:0000978Bruising susceptibility0WAS CL E G H745412731ORPHA:906Wiskott-Aldrich syndromeHP:0040281 - Very frequent65
HP:0000978HP:0000978Bruising susceptibility0WIPF1 CL E G H745612736ORPHA:906Wiskott-Aldrich syndromeHP:0040281 - Very frequent6
HP:0000978HP:0000978Bruising susceptibility0ZBTB16 CL E G H770412930ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent1
HP:0000978HP:0000978Bruising susceptibility0ZNF469 CL E G H8462723216ORPHA:90354Brittle cornea syndromeHP:0040282 - Frequent397


Genes (158) :ABCC6 ACTA2 ADAMTS2 AEBP1 AIP ANKRD26 ARMC5 ATP7A ATP7B ATRX B3GALT6 BCOR BLOC1S3 BLOC1S5 BRAF C1R C1S CASP10 CDH23 CHST14 CLCN7 COL1A1 COL1A2 COL3A1 COL5A1 COL5A2 CREB3L1 DSE DTNBP1 ELN EMILIN1 ENPP1 ETV6 F10 F13A1 F13B F2 F5 F7 F8 FANCA FANCC FANCD2 FANCE FAS FASLG FBN1 FCGR2C FGA FGB FGG FIP1L1 FKBP14 FLNA FOXE3 GATA1 GATA2 GBA1 GFI1B GGCX GNAS GP1BA GP1BB GP6 GP9 GSN HBA1 HBA2 HEY2 HPS1 HPS3 HPS4 HPS5 HPS6 IPO8 IRF2BP2 ITGA2B ITGB3 JAK2 KRAS LMAN1 LOX LYST MAP2K1 MAPK1 MAT2A MCFD2 MFAP5 MPL MTAP MYH11 MYH9 MYLK NABP1 NBEAL2 NFIX NPM1 NR3C1 NTRK1 NUMA1 P2RY12 PDE11A PDE8B PLAU PLEC PLOD1 PLOD3 PML PRDM5 PRF1 PRKACA PRKAR1A PRKCD PRKG1 PTPN11 PYCR1 RARA RASGRP1 RIN2 RUNX1 SCARB2 SERPINF2 SIK3 SLC2A10 SLC37A4 SLC39A13 SLC51A SLFN14 SMAD2 SMAD3 SMAD4 SNX10 SOS1 SPRED2 STAT3 STAT5B STX11 STXBP2 TBL1XR1 TBXA2R TCIRG1 TET2 TGFB2 TGFB3 TGFBR1 TGFBR2 TNFRSF1A TNFSF11 TNXB TP53 UNC13D USP48 USP8 VWF WAS WIPF1 ZBTB16 ZNF469

Diseases (139) :ORPHA:758 ORPHA:91387 OMIM:225410 ORPHA:536532 OMIM:618000 OMIM:219090 OMIM:188000 ORPHA:189427 OMIM:304150 ORPHA:198 ORPHA:905 ORPHA:231401 ORPHA:96253 ORPHA:536467 ORPHA:520 OMIM:614077 OMIM:619172 OMIM:163950 OMIM:130080 OMIM:617174 ORPHA:3261 OMIM:601776 ORPHA:2953 ORPHA:667 ORPHA:287 OMIM:619115 OMIM:130060 OMIM:166200 ORPHA:230851 OMIM:619120 OMIM:617821 OMIM:225320 OMIM:130050 OMIM:618343 ORPHA:286 OMIM:130000 OMIM:130010 OMIM:616229 OMIM:614076 OMIM:620080 OMIM:616216 ORPHA:328 ORPHA:331 OMIM:613225 OMIM:613235 OMIM:613679 ORPHA:326 OMIM:227400 ORPHA:327 ORPHA:177926 OMIM:306700 ORPHA:169802 OMIM:227650 OMIM:227645 OMIM:227646 OMIM:600901 OMIM:616914 ORPHA:3002 OMIM:202400 OMIM:614557 ORPHA:300179 ORPHA:75497 OMIM:314050 OMIM:300367 ORPHA:3226 ORPHA:77259 OMIM:187900 OMIM:277450 OMIM:219080 ORPHA:274 OMIM:153670 OMIM:614201 ORPHA:85448 ORPHA:98791 OMIM:203300 OMIM:614072 OMIM:614073 OMIM:614074 OMIM:614075 ORPHA:60030 OMIM:619472 ORPHA:849 OMIM:273800 OMIM:619267 ORPHA:729 OMIM:609942 ORPHA:35909 ORPHA:352723 ORPHA:167 OMIM:214500 OMIM:619087 OMIM:112250 OMIM:155100 ORPHA:182050 OMIM:139090 ORPHA:721 ORPHA:561 ORPHA:642 OMIM:609821 ORPHA:1359 OMIM:610475 ORPHA:189439 OMIM:601709 OMIM:131950 OMIM:225400 ORPHA:1900 OMIM:612394 ORPHA:90354 ORPHA:540 OMIM:615830 OMIM:610489 OMIM:612940 OMIM:613075 ORPHA:217335 OMIM:601399 ORPHA:79 OMIM:262850 OMIM:618162 OMIM:208050 ORPHA:79259 OMIM:612350 ORPHA:157965 OMIM:619484 OMIM:616913 ORPHA:284984 OMIM:613795 OMIM:610733 OMIM:619745 OMIM:614009 OMIM:614816 OMIM:615582 ORPHA:32960 ORPHA:230839 OMIM:606408 OMIM:193400 OMIM:613554 OMIM:277480 OMIM:313900 ORPHA:906
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.